Rupichrysenoids A–H, phytocannabinoid-like meroterpenoids from Rhododendron rupicola var. chryseum: Isolation, structure, and bioactivity
Phytochemistry · 2026-08 · 248 · 114901
DOI: 10.1016/j.phytochem.2026.114901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2026-08. Verfasst von Ai-Chun Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Science and Technology, Yunnan University, Kunming, 650500, People's Republic of China; State Key Laboratory of Phytochemistry and…. Hauptthemen laut MEDLINE: Rhododendron, Anti-Bacterial Agents, Terpenes, Glycoside Hydrolase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
The first phytochemical investigation on the aerial parts of Rhododendron rupicola var. Chryseum led to the discovery of eight previously undescribed phytocannabinoid-like meroterpenoids (PLMs), named rupichrysenoids A-H (1-8), along with two previously reported ones (9 and 10). The structural establishment of PLMs 1-8 was achieved by means of spectroscopic data (NMR and HRMS) analysis, ECD calculations, and single crystal X-ray diffraction, as well as NMR calculations and DP4+ probability analyses. PLMs 2 and 10 showed significant α-glucosidase inhibitory effects with IC50 values of 16.73 ± 1.07 and 27.94 ± 1.08 μM, respectively. Molecular docking studies uncovered that the formation of hydrogen bonds of PLMs 2 and 10 with residues Lys-150, Pro-312, and Leu-313 of α-glucosidase might play crucial roles in their bioactive effects. In addition, PLM 10 exhibited significant antibacterial activities against MRSA (methicillin-resistant Staphylococcus aureus) and VRE (vancomycin-resistant Enterococci) with MIC value of both 2 μg/mL. These findings could provide potential candidates for the further development of antidiabetic and antibacterial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Science and Technology, Yunnan University, Kunming, 650500, People's Republic of China; State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sc…
- State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, People's Republic of China; University of Chinese Academy of Sciences, Beijing, 10…
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Lu, A. C., Zong, W. Y., Luo, E. E., Pan, Y., Lei, S. M., & Qin, X. J. (2026). Rupichrysenoids A–H, phytocannabinoid-like meroterpenoids from Rhododendron rupicola var. chryseum: Isolation, structure, and bioactivity. Phytochemistry, 248, 114901. https://doi.org/10.1016/j.phytochem.2026.114901
Vancouver
Lu AC, Zong WY, Luo EE, Pan Y, Lei SM, Qin XJ. Rupichrysenoids A–H, phytocannabinoid-like meroterpenoids from Rhododendron rupicola var. chryseum: Isolation, structure, and bioactivity. Phytochemistry. 2026;248:114901. doi:10.1016/j.phytochem.2026.114901
BibTeX
@article{Lu2026,
author = {Lu, Ai-Chun and Zong, Wen-Ying and Luo, E-E and Pan, Yu and Lei, Shu-Mei and Qin, Xu-Jie},
title = {Rupichrysenoids A–H, phytocannabinoid-like meroterpenoids from Rhododendron rupicola var. chryseum: Isolation, structure, and bioactivity},
journal = {Phytochemistry},
year = {2026},
volume = {248},
pages = {114901},
doi = {10.1016/j.phytochem.2026.114901}
}
EUVIMED